Vanderbilt Clinical Trials

Cognitive Enhancement in Depression (The COG-D Study)

Purpose

This study will investigate whether transcranial direct current stimulation (tDCS) enhances the effects of cognitive training in older adults with depression.

Conditions

Aging
Depression
Cognitive Symptom

Eligibility

Eligible Ages: Over 60 Years
Eligible Genders: All
Accepts Healthy Volunteers: No

Inclusion Criteria

Age 60+ years - Diagnosis of Major Depressive Disorder (MDD; Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria) - Either stable antidepressant regimen for at least 6 weeks or no current antidepressant treatment - Depression severity of 15+ on the MADRS - Evidence of subjective cognitive complaints on the Everyday Cognition Scale (ECog) - English fluency

Exclusion Criteria

Other Axis I psychiatric disorders, except for generalized anxiety disorder (GAD) symptoms occurring in a depressive episode - Acute suicidality on clinical evaluation - Currently taking medications that would significantly interact with tDCS effects (such as sodium channel blockers or anticonvulsants) - Neurological disorders (e.g., dementia, stroke, seizures, traumatic brain injury, Parkinson's disease) - Montreal Cognitive Assessment (MoCA) score < 23 - Primary amnestic cognitive profile (>1.5 standard deviations (SDs) below demographically-adjusted mean on National Alzheimer's Coordinating Center (NACC) memory measures in context of otherwise normal cognitive profile) - Any physical or intellectual disability affecting ability to complete assessments - Unstable medical illness needing urgent treatment - MRI contraindications - Electroconvulsive therapy (ECT) or transcranial magnetic stimulation (TMS) in last 2 months - Current involvement in psychotherapy - Current involvement in other research studies (including but not limited to: neuromodulation [TMS or tDCS] or investigational drug studies)

Study Design

Phase: N/A
Study Type: Interventional
Allocation: Randomized
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
Masking: Double (Participant, Investigator)
Masking Description: Double-blind

Arm Groups

Arm	Description	Assigned Intervention
Experimental Cognitive Training + Active Stimulation	This arm receives cognitive training combined with active tDCS.	Behavioral: Cognitive Training Computerized cognitive training targeting the underlying cerebral networks associated with depression. Device: tDCS (active stimulation) A Soterix Clinical Trials Direct Current Stimulator will apply 20 minutes of 2.0 milliamps (mA) direct current through two bicarbon rubber electrodes encased in saline soaked 5 cm x 7 cm sponges (8 cc of 0.9% saline solution per sponge) placed over the frontal cortices at F3 and F4 (via 10-20 system).
Experimental Cognitive Training + Sham Stimulation	This arm receives cognitive training combined with sham tDCS.	Behavioral: Cognitive Training Computerized cognitive training targeting the underlying cerebral networks associated with depression. Device: tDCS (sham stimulation) Sham stimulation will be performed with the same device and all procedures will be identical except for the duration of stimulation. Participants will receive 30 seconds of 2 mA of direct current stimulation at the beginning of the session. Participants habituate to the sensation of tDCS within 30-60 seconds of stimulation. This procedure provides the same sensation of tDCS without the full duration of stimulation, making it a highly effective sham procedure.

Recruiting Locations

Vanderbilt University Medical Center
Nashville, Tennessee 37212

Contact:
Sarah M Szymkowicz, PhD
615-875-0032
sarah.szymkowicz@vumc.org

More Details

Status: Recruiting
Sponsor: Vanderbilt University Medical Center

Study Contact

Sarah M. Szymkowicz, PhD
615-875-0032
sarah.szymkowicz@vumc.org

Detailed Description

The purpose of this study is to determine whether the addition of active tDCS to computerized cognitive remediation (nCCR) enhances brain activity and cognitive functions in older adults with depression to a greater degree than nCCR with sham stimulation. The investigators will randomize 20 elderly depressed outpatients to either double-blinded active or sham bifrontal tDCS plus daily nCCR over 4-weeks. Multimodal MRI (focused on the cognitive control network; CCN) and psychiatric and neuropsychological evaluations will be obtained at baseline and following intervention completion. Long-term CCN cognitive effects will be explored 3-months post-intervention via cognitive assessments.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.